Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration

Mingyao Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chen Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Signal Transduction and Targeted Therapy
May 13, 2022
Cited by 83


Related Papers